Original Source(s)
Related Content
Immature granulocytes may signal pediatric lupus activity
Automated blood cell measurements distinguished active disease from remission with performance comparable to ESR in a small pediatric cohort.
November 5, 2026
-
4 min
FDA expands talazoparib use in prostate cancer
The combination with enzalutamide reduced the risk of radiographic progression or death by 52% .
by Mouj Hijazi
October 27, 2026
-
3 min
FDA, CMS target gene therapy barriers
FDA and CMS initiatives aim to simplify gene therapy approvals and expand access to treatments for rare diseases.
by Mouj Hijazi
October 29, 2026
-
4 min
